Brain-Reactive Antibodies are Potential Biomarkers for Evaluating Therapeutic Efficacy in NPSLE Patients
Xiujiao Wang,1,* Dongju Feng,2,* Yao Ke,1 Lei Gu,1 Chengyin Lv,1 Miaojia Zhang,1 Qiang Wang,1 Yanyan Wang1 1Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of China; 2Department of Immunology, Nanjin...
Main Authors: | Wang X, Feng D, Ke Y, Gu L, Lv C, Zhang M, Wang Q, Wang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-07-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/brain-reactive-antibodies-are-potential-biomarkers-for-evaluating-ther-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Mouse models, antibodies, and neuroimaging: Current knowledge and future perspectives in neuropsychiatric systemic lupus erythematosus (NPSLE)
by: Vanessa Tomalla, et al.
Published: (2023-03-01) -
Definition of NPSLE: Does the ACR Nomenclature Still Hold?
by: Jessica Fernandes Vivaldo, et al.
Published: (2018-05-01) -
Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus
by: Mansoor Karimifar, et al.
Published: (2013-01-01) -
Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
by: Angel A. Justiz-Vaillant, et al.
Published: (2024-02-01) -
Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report
by: Lingshu Zhang, et al.
Published: (2023-03-01)